< Terug naar vorige pagina

Publicatie

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

Tijdschriftbijdrage - Tijdschriftartikel

Docetaxel/cisplatin/infusional 5-fluorouracil (DCF) is a standard chemotherapy regimen for patients with advanced gastric cancer. This phase II study evaluated docetaxel/oxaliplatin (TE), docetaxel/oxaliplatin/5-fluorouracil (TEF) and docetaxel/oxaliplatin/capecitabine (TEX) in patients with advanced gastric cancer.
Tijdschrift: ANNALS OF ONCOLOGY
ISSN: 0923-7534
Issue: 1
Volume: 26
Pagina's: 149 - 56
Jaar van publicatie:2015
BOF-keylabel:ja
IOF-keylabel:ja
BOF-publication weight:10
CSS-citation score:3
Auteurs:International
Authors from:Higher Education